GSK-3/CDK5/CDK2-IN-1

Names

[ Name ]:
GSK-3/CDK5/CDK2-IN-1

Biological Activity

[Description]:

GSK-3/CDK5/CDK2-IN-1, an imidazole derivative, is an inhibitor of cdk5, cdk2, and GSK-3 extracted from patent WO2002010141A1, example 9a. GSK-3/CDK5/CDK2-IN-1 can be used for the research of cancer, and neurodegenerative diseases.

Chemical & Physical Properties

[ Molecular Formula ]:
C₂₁H₂₂N₄O₂

[ Molecular Weight ]:
362.42

Related Compounds

HDAC1/2 and CDK2-IN-1
4-Cyclohexyl-buten-(3)-in-(1)
FGFR2/3-IN-1
Galectin-3-IN-1
EGFR/CDK2-IN-1
SIRT1/2/3-IN-1
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
N'-(methylamino)ethanimidamide hydrochloride
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
[6-(Diethylamino)-5-methylpyridin-2-yl]methanol
(4-Methyl-tetrahydro-furan-2-yl)-methanol
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
tert-Butyl-DL-alanine